Keosys-Blog-Graphic-1

The Keosys Blog

Expert insights into medical imaging in clinical trials.
Keosys
Interview: A Clinical R&D Expert Talks About the Future of Radiopharmaceuticals
With a background in clinical research and development, UK-trained physician..
Keosys
Why are so many imaging queries sent to your site and how can you avoid them?
Why are so many imaging queries sent to your site and how can you avoid them?..
Keosys
Heptocellular Carcinoma (HCC) Resource Page
Hepatocellular Carcinoma (HCC) is the most common cancer of the liver and the..
Keosys
Focus On Selective Internal Radiation Therapy with HCC
This is an excerpt from our free eBook, “Hepatocellular Carcinoma and Imaging..
Keosys
Evaluating Tumor Response in HCC
This is an excerpt from our free eBook, “Hepatocellular Carcinoma and Imaging..
Keosys
Interview: An Interventional Radiologist Talks About Radioembolization in the Treatment of HCC Today
Dr. Yan Rolland, head of the diagnosis and interventional radiology department..
Keosys
Interview: A Radiology Professor Talks About mRECIST, Reading Images in Clinical Trials, and More
Maxime Ronot, Professor at the Université de Paris, and Radiologist in the..
Keosys
Interview: Keosys Advances into a Promising New Year
With our 20th anniversary year recently completed and a new year underway, we..
Case Study - Setting up a Project in a Short Turnaround Time
Sometimes sponsors and CROs are not sure in the early stages of a trial that..
Modified Recist for HCC with Infographic
mRECIST was developed in 2010 to adapt RECIST v1.1 to the particularities of..
Questions to Ask Yourself About Imaging in Clinical Trials
Starting a trial can be very challenging. There are many actors involved and..

More Posts

New call-to-action